Literature DB >> 1360338

Postoperative analgesia: opioid infusions in infants and children.

D R Pounder1, D J Steward.   

Abstract

The purpose of this review is to emphasise the ineffectiveness of traditional analgesic therapy in paediatric patients after surgery, to examine the sensation of pain in infants and children, and to describe the use of intravenous opioids for postoperative analgesia. The management of acute postoperative pain in the paediatric surgical population has been poor. This is despite the knowledge that infants and children have sufficient neurological development at birth to sense pain, and that the same hormonal and metabolic responses to nociceptive stimuli that occur in adult also occur in the neonate. Physicians frequently order analgesics in inappropriate doses, nurses are reluctant to administer opioids, and children themselves frequently compound the problem by refusing injections. The sophisticated techniques for providing postoperative analgesia which have been used so successfully in adults can also be used in paediatric patients. Two of these, continuous intravenous opioid infusion and patient-controlled analgesia, have proved to be very successful. Children older than six months can receive either modality safely with regular monitoring by qualified nursing staff. Infants younger than six months receiving continuous opioid infusions should be monitored in high-dependency units.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360338     DOI: 10.1007/BF03008348

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  26 in total

1.  Patient-controlled analgesia--the value of a background infusion.

Authors:  M Y Wu; G J Purcell
Journal:  Anaesth Intensive Care       Date:  1990-11       Impact factor: 1.669

2.  Reduction of postoperative morbidity following patient-controlled morphine.

Authors:  T J Wasylak; F V Abbott; M J English; M E Jeans
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

3.  Postoperative analgesia provided by morphine infusion in children.

Authors:  R J Bray
Journal:  Anaesthesia       Date:  1983-11       Impact factor: 6.955

4.  Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy.

Authors:  A W Miser; J S Miser; B S Clark
Journal:  J Pediatr       Date:  1980-05       Impact factor: 4.406

5.  An evaluation of morphine and oxymorphone administered via patient-controlled analgesia (PCA) or PCA plus basal infusion in postcesarean-delivery patients.

Authors:  R Sinatra; K S Chung; D G Silverman; S J Brull; J Chung; D M Harrison; D Donielson; A Weinstock
Journal:  Anesthesiology       Date:  1989-10       Impact factor: 7.892

6.  Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety.

Authors:  G Koren; W Butt; H Chinyanga; S Soldin; Y K Tan; K Pape
Journal:  J Pediatr       Date:  1985-12       Impact factor: 4.406

7.  Status of pediatric pain control: a comparison of hospital analgesic usage in children and adults.

Authors:  N L Schechter; D A Allen; K Hanson
Journal:  Pediatrics       Date:  1986-01       Impact factor: 7.124

8.  Kinetics and dynamics of postoperative intravenous morphine in children.

Authors:  K T Olkkola; E L Maunuksela; R Korpela; P H Rosenberg
Journal:  Clin Pharmacol Ther       Date:  1988-08       Impact factor: 6.875

9.  Incidence and characteristics of pain in a sample of medical-surgical inpatients.

Authors:  Marilee Donovan; Paula Dillon; Lora McGuire
Journal:  Pain       Date:  1987-07       Impact factor: 6.961

10.  Postoperative analgesia in children: a prospective study in intermittent intramuscular injection versus continuous intravenous infusion of morphine.

Authors:  M Hendrickson; L Myre; D G Johnson; M E Matlak; R E Black; J J Sullivan
Journal:  J Pediatr Surg       Date:  1990-02       Impact factor: 2.545

View more
  1 in total

Review 1.  Choosing the right analgesic. A guide to selection.

Authors:  Timothy G Bushnell; Douglas M Justins
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.